Bill Lundberg

CRISPR Therapeutics announced the appointment of Bill Lundberg as chief scientific officer. Lundberg will lead the firm's development programs and R&D operations in Cambridge, Mass. He comes to CRISPR Therapeutics from Alexion Pharmaceuticals, where he was vice president and head of Translational Medicine. He has also held posts at Taligen Therapeutics, Genzyme, and Wyeth.